Boris and Rose Katz Professor of Neurology, Director of the Alzheimer’s Disease Research Center, Columbia University
Scott A. Small M.D. is the Director of the Alzheimer’s Disease Research Center at Columbia University, where he also directs the Psychosis Research Program.
Dr. Small focuses on disorders that affect the hippocampus, a brain structure targeted by Alzheimer’s disease, schizophrenia, and the normal wear & tear of the aging process. The hippocampus is a circuit comprised of a handful of microscopic regions. The overarching hypothesis motivating Dr. Small’s lab is that if hippocampal regions most vulnerable to a disorder can be pinpointed, this anatomical information can guide a search for the disorder’s root cause.
Accordingly, Dr. Small’s ‘anatomical biology’ lab has pioneered the development of MRI tools best suited to isolate vulnerable hippocampal regions. His lab has then used this information to identify mechanisms that are now thought to underlie Alzheimer’s disease, schizophrenia, and ‘cognitive aging’. Most recently, his lab has begun developing interventions for each condition. To date, the lab has completed two clinical trials for cognitive aging and one for schizophrenia, and the lab’s Alzheimer’s disease findings was the cornerstone around which a new biotechnology company, Retromer Therapeutics. was formed.
Steps to claim CME credits for BWH Neurology Grand Rounds 2020-2021:
Text this code "RUXVOC” to 1-857-214-2277.
- A link will be sent to your email. Click on the link and complete the evaluation. After you complete the evaluation, your CME will be recorded. You will then be able to download a PDF of your certificate.
If you have any questions about the CME credit, please contact Partners Office of Continuing Professional Development at PartnersCPD@partners.org.
